Pharma, bio tech & life sciences

Skip to content
Skip to navigation

India's pharmaceutical, biotechnology, and life sciences sector is one of the fastest-growing industries globally, fueled by an expanding domestic market.

Despite facing challenges such as regulatory hurdles, a shortage of skilled workers, high research and development costs, and intellectual property issues, the sector is poised for growth. Government support, strategic policy interventions, and the encouragement of foreign direct investment (FDI) are expected to stimulate further development in this dynamic industry.

Watch the recording

Union Budget 2026 webinar

A detailed discussion on Union Budget 2026 announcements and their relevance for businesses and India’s economic landscape.

The video is playing. This video is playing in mini-player mode.

Advisory on a global level

Our private healthcare advisory teams operate on a global level and offer insights and practical guidance in the UK and internationally.

Practical experience

We have years of practical industry experience, which guarantees our understanding of the distinctive aspects that characterise your market.

Sector knowledge

Our technical expertise spans across the entire sector, from primary and secondary care providers to medical device companies, retail healthcare providers, and healthcare distributors.

AI and life sciences: Navigating risks and challenges

As AI continues to transform other sectors, the life sciences industry has only recently begun to realize its full potential.

Our insights

View all

Indian multinational pharmaceutical company

Problem statement

The client wanted to examine and review annual GST compliances to identify any non-compliances, process gaps, and scope for improvement.

Our Solution

We reviewed the client's compliance processes to identify lapses in procedures, positions, and documentation. We implemented controls to prevent the misuse of input tax credits (ITC) across states and to ensure timely issuance of credit...

Impact

The efficiency of the client’s compliance process improved, building tax efficiency in their entities and reducing the cost borne by them due to non-compliance and lapses in the process.

Assisting a pharma firm with end-to-end tax compliance

Problem statement

While performing their day-to-day compliances under the erstwhile indirect tax regime and later on with the advent of Goods and Services Tax (GST) law w.e.f. 1 July 2017, a fortune 500 pharmaceutical company was looking for a one-point...

Our Solution

Our experts initially guided the client through comprehensive compliances under the previous tax regime, improving their complex data collation processes, and later expanded our role to include assessments and litigation support. With the...

Impact

The client was able to streamline their ERP and IT systems, enabling a hassle-free process of filing GST returns and issuance of e-invoices under GST. Further, our prompt proposition led to the successful closure of numerous litigations...

Data architect and modelling for Blackline implementation

Problem statement

The client, as part of their growth strategy, was executing a large finance transformation (FT) programme with multiple initiatives. In this regard, they wanted expertise in data architecture with profiling and modelling capabilities to...

Our Solution

Our team quickly began working on the transformation programme which was mid-way. Engagement was initiated with global stakeholder groups to identify the modelling requirements for open item matching and balance sheet quality. Our project...

Impact

In 12 Months, our team delivered the engagement expectation along with a detailed reusable data model for balance sheet reconciliation, improving accuracy and efficiency. The data model to capture the difference in volume between FI and...

Pharma, bio tech & life sciences